Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36 Washington Street, Wellesley Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Albendazole | C12H15N3O2S | 54965-21-8 | Details |
| Camicinal；GSK962040 | C25H33FN4O | 923565-21-3 | Details |
| GSK-J2 | C22H23N5O2 | 1394854-52-4 | Details |
| GSK-3 inhibitor 1 | C22H17ClFN5O2 | 603272-51-1 | Details |
| Fiboflapon；AM-803;GSK2190915 | C38H43N3O4S | 936350-00-4 | Details |
| Golotimod | C16H19N3O5 | 229305-39-9 | Details |
| Guanfu base H；Atisinium chloride | C22H34ClNO2 | 4758-99-0 | Details |
| GlyRS-IN-1 | C12H17N7O7S | 112921-11-6 | Details |
| GPR120 Agonist 1 | C20H12ClF6NO3S | 1628448-77-0 | Details |
| GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
| GSK2593074A | C27H23N5OS | 1337531-06-2 | Details |
| GSK598809 | C22H23F4N5OS | 863680-45-9 | Details |
| GSK-3β inhibitor 1 | C14H10N2O | 187325-53-7 | Details |
| Lenacapavir | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
| GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
| GPR120 modulator 1 | C19H16ClNO4S | 1050506-75-6 | Details |
| GPR40 Activator 2 | C28H29NO6S2 | 1312787-30-6 | Details |
| Guanfu base I；Acorine | C22H29NO5 | 110225-59-7 | Details |
| GSK2239633A | C24H25ClN4O5S2 | 1240516-71-5 | Details |
| Molibresib besylate；GSK 525762C;I-BET 762 besylate | C28H28ClN5O5S | 1895049-20-3 | Details |
| GPR40/FFAR1 modulator 1 | C21H19N5O3 | 874755-26-7 | Details |
| Roxithromycin | C41H76N2O15 | 80214-83-1 | Details |
| Gum arabic；Arabic gum | N/A | 9000-01-5 | Details |
| GSTO1-IN-1 | C10H12Cl2N2O3S | 568544-03-6 | Details |
| GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
| H-89 | C20H20BrN3O2S | 127243-85-0 | Details |
| GPR120 modulator 2 | C20H18ClNO3S | 1050506-87-0 | Details |
| GSK256066 Trifluoroacetate；GSK 256066 Trifluoroacetate;GSK256066 (2,2,2-trifluoroacetic acid) | C29H27F3N4O7S | 1415560-64-3 | Details |
| GSK 525768A | C22H22ClN5O2 | 1260530-25-3 | Details |
| GW806742X | C25H22F3N7O4S | 579515-63-2 | Details |
| GSK2850163 | C24H29Cl2N3O | 2121989-91-9 | Details |
| GNE-8505 | C21H24F3N5O | 1620573-48-9 | Details |
| GW 766994；GW 994 | C21H24Cl2N4O3 | 408303-43-5 | Details |
| GSK205 | C24H25BrN4S | 1263068-83-2 | Details |
| GW274150 | C8H17N3O2S | 210354-22-6 | Details |
| GPI-1046 | C20H28N2O4 | 186452-09-5 | Details |
| Gosogliptin；PF-00734200;PF-734200 | C17H24F2N6O | 869490-23-3 | Details |
| Camicinal hydrochloride；GSK962040 hydrochloride | C25H34ClFN4O | 923565-22-4 | Details |
| GNF179 (Metabolite)；GNF179 Metabolite | C14H16FN3 | 1310455-86-7 | Details |
| Fiboflapon sodium；GSK2190915 sodium salt;AM-803 sodium | C38H44N3NaO4S | 1196070-26-4 | Details |
| GNF-6231 | C24H25FN6O2 | 1243245-18-2 | Details |
| GSK2245035 | C20H34N6O2 | 1207629-49-9 | Details |
| GSK-843 | C19H15N5S2 | 1601496-05-2 | Details |
| Menbutone | C15H14O4 | 3562-99-0 | Details |
| GNF362 | C22H21F3N6 | 1003019-41-7 | Details |
| Lidocaine hydrochloride | C14H23ClN2O | 73-78-9 | Details |
| Guanoxabenz；Hydroxyguanabenz | C8H8Cl2N4O | 24047-25-4 | Details |
| GPR40 Activator 1 | C31H31NO3S | 1309435-60-6 | Details |
| GRL0617 | C20H20N2O | 1093070-16-6 | Details |
| GNA002 | C42H55NO8 | 1385035-79-9 | Details |
| GSK4028 | C17H21BrN4O | 2079886-19-2 | Details |
| Lidocaine Hydrochloride hydrate | C14H25ClN2O2 | 6108-05-0 | Details |
| GSK1521498 | C24H23F2N4O4P | 1426543-84-1 | Details |
| Ganfeborole HCl | C10H14BCl2NO4 | 2131798-13-3 | Details |
| GPR84 antagonist 8 | C23H23N3O5 | 1445846-30-9 | Details |
| GNF4877 | C25H27FN6O4 | 2041073-22-5 | Details |
| GSK3368715 dihydrochloride | C20H39ClN4O2 | 1628925-77-8 | Details |
| GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
| GSK-3β inhibitor 2 | C14H14N4O3S | 1702428-31-6 | Details |
| GW274150 phosphate | C8H20N3O6PS | 438542-15-5 | Details |
| GPR4 antagonist 1 | C27H37N5 | 1197879-16-5 | Details |
| Nifedipine；Procardia XL;Procardia;BAY-a-1040;Adalat | C17H18N2O6 | 21829-25-4 | Details |
| GSK-5498A | C18H11F6N3O | 1253186-49-0 | Details |
| GSK1059865 | C20H23BrFN3O2 | 1191044-58-2 | Details |
| GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
| Epelsiban；GSK 557296 | C30H38N4O4 | 872599-83-2 | Details |
| GSK682753A | C23H21Cl3N2O3 | 1334294-76-6 | Details |
| GSK2945 | C20H18Cl2N2O2S | 1438071-12-5 | Details |
| GSK3532795；BMS-955176 | C42H62N2O4S | 1392312-45-6 | Details |
| GNE-0439 | C21H31NO3 | 1241902-40-8 | Details |
| Glyoxalase I inhibitor | C21H30BrClN4O8S | 221174-33-0 | Details |
| Guanosine-5'-triphosphate disodium salt | C10H17N5NaO14P3 | 56001-37-7 | Details |
| GSK1521498 free base | C24H20F2N4 | 1007573-18-3 | Details |
| NE 52-QQ57 | C24H28N6O | 1401728-56-0 | Details |
| Chlorhexidine dihydrochloride；Chlorhexidine 2HCl;NSC-185;Chlorhexidine hydrochloride | C22H32Cl4N10 | 3697-42-5 | Details |
| Fenofibrate | C20H21ClO4 | 49562-28-9 | Details |
| GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
| GSK 366 | C17H16ClN3O4 | 1953157-39-5 | Details |
| GZD856 | C29H27F3N6O | 1257628-64-0 | Details |
| GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
| GSK-3484862 | C19H19N5OS | 2170136-65-7 | Details |
| Guancydine；Guancidine | C7H14N4 | 1113-10-6 | Details |
| Gusperimus trihydrochloride；BMS181173;NKT-01;Spanidin | C17H37N7O3.3ClH | 85468-01-5 | Details |
| Diminazene Aceturate | C22H29N9O6 | 908-54-3 | Details |
| GR 103691 | C30H35N3O3 | 162408-66-4 | Details |
| GSK2983559 free acid | C21H23N4O7PS2 | 1579965-12-0 | Details |
| GSK 4027 | C17H21BrN4O | 2079896-25-4 | Details |
| GSTO-IN-2 | C33H52N2O9 | 1202710-57-3 | Details |
| GSK726701A | C24H22FNO5 | 945721-87-9 | Details |
| GSK840；GSK'840 | C21H23N3O3 | 2361146-30-5 | Details |
| GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
| GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
| GOAT-IN-1 | C18H13ClF3NO3S | 1452473-54-9 | Details |
| Guaiapate | C18H29NO4 | 852-42-6 | Details |
| GSK-2793660 | C20H27N3O3 | 1613458-70-0 | Details |
| GSK3368715；EPZ019997 | C20H38N4O2 | 1629013-22-4 | Details |
| GV-58 | C18H26N6OS | 1402821-41-3 | Details |
| GSK2807 Trifluoroacetate | C21H33F3N8O7 | 2245255-66-5 | Details |
| GNE 220 | C25H26N8 | 1199590-75-4 | Details |
| GV-196771A | C20H15Cl2N2NaO3 | 166974-23-8 | Details |
| Product Total： Product Page： | ||||
| 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 | ||||